These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38890271)

  • 1. Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms.
    Ferrer P; Berry AA; Bucsan AN; Prajapati SK; Krishnan K; Barbeau MC; Rickert DM; Guerrero SM; Usui M; Abebe Y; Patil A; Chakravarty S; Billingsley PF; Pa'ahana-Brown F; Strauss K; Shrestha B; Nomicos E; Deye GA; Sim BKL; Hoffman SL; Williamson KC; Lyke KE
    Nat Commun; 2024 Jun; 15(1):5194. PubMed ID: 38890271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
    Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
    PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
    Elias SC; Choudhary P; de Cassan SC; Biswas S; Collins KA; Halstead FD; Bliss CM; Ewer KJ; Hodgson SH; Duncan CJ; Hill AV; Draper SJ
    Immunology; 2014 Apr; 141(4):628-44. PubMed ID: 24303947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens.
    Hall CE; Hagan LM; Bergmann-Leitner E; Tosh DM; Bennett JW; Regules JA; Chuang I; Angov E; Dutta S; Chattopadhyay D; Yadava A
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30559218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful human infection with P. falciparum using three aseptic Anopheles stephensi mosquitoes: a new model for controlled human malaria infection.
    Laurens MB; Billingsley P; Richman A; Eappen AG; Adams M; Li T; Chakravarty S; Gunasekera A; Jacob CG; Sim BK; Edelman R; Plowe CV; Hoffman SL; Lyke KE
    PLoS One; 2013; 8(7):e68969. PubMed ID: 23874828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.
    Ishizuka AS; Lyke KE; DeZure A; Berry AA; Richie TL; Mendoza FH; Enama ME; Gordon IJ; Chang LJ; Sarwar UN; Zephir KL; Holman LA; James ER; Billingsley PF; Gunasekera A; Chakravarty S; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; K C N; Murshedkar T; DeCederfelt H; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Laurens MB; Plowe CV; Flynn B; Whalen WR; Todd JP; Noor J; Rao S; Sierra-Davidson K; Lynn GM; Epstein JE; Kemp MA; Fahle GA; Mikolajczak SA; Fishbaugher M; Sack BK; Kappe SH; Davidson SA; Garver LS; Björkström NK; Nason MC; Graham BS; Roederer M; Sim BK; Hoffman SL; Ledgerwood JE; Seder RA
    Nat Med; 2016 Jun; 22(6):614-23. PubMed ID: 27158907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.
    Tamminga C; Sedegah M; Maiolatesi S; Fedders C; Reyes S; Reyes A; Vasquez C; Alcorta Y; Chuang I; Spring M; Kavanaugh M; Ganeshan H; Huang J; Belmonte M; Abot E; Belmonte A; Banania J; Farooq F; Murphy J; Komisar J; Richie NO; Bennett J; Limbach K; Patterson NB; Bruder JT; Shi M; Miller E; Dutta S; Diggs C; Soisson LA; Hollingdale MR; Epstein JE; Richie TL
    Hum Vaccin Immunother; 2013 Oct; 9(10):2165-77. PubMed ID: 23899517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
    John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
    Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of anti-Plasmodium IgG profiles among Fulani nomadic pastoralists in northern Senegal to assess malaria exposure.
    Seck MC; Thwing J; Badiane AS; Rogier E; Fall FB; Ndiaye PI; Diongue K; Mbow M; Ndiaye M; Diallo MA; Gomis JF; Mbaye A; Ndiaye T; Gaye A; Sy M; Déme AB; Ndiaye YD; Ndiaye D
    Malar J; 2020 Jan; 19(1):15. PubMed ID: 31931834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated rubella vectors expressing Plasmodium falciparum circumsporozoite protein (Pf-CSP) provide a novel malaria vaccine platform in the rhesus macaque.
    Virnik K; Zhou W; Medvedev A; Walsh G; Perry-Anderson J; Majam V; Felber BK; Kumar S; Berkower I
    Biochem Biophys Res Commun; 2021 Nov; 577():58-63. PubMed ID: 34507066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
    Chuang I; Sedegah M; Cicatelli S; Spring M; Polhemus M; Tamminga C; Patterson N; Guerrero M; Bennett JW; McGrath S; Ganeshan H; Belmonte M; Farooq F; Abot E; Banania JG; Huang J; Newcomer R; Rein L; Litilit D; Richie NO; Wood C; Murphy J; Sauerwein R; Hermsen CC; McCoy AJ; Kamau E; Cummings J; Komisar J; Sutamihardja A; Shi M; Epstein JE; Maiolatesi S; Tosh D; Limbach K; Angov E; Bergmann-Leitner E; Bruder JT; Doolan DL; King CR; Carucci D; Dutta S; Soisson L; Diggs C; Hollingdale MR; Ockenhouse CF; Richie TL
    PLoS One; 2013; 8(2):e55571. PubMed ID: 23457473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Human Malaria Infection with Graded Numbers of
    Langenberg MCC; Wammes LJ; McCall MBB; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer MG; Teelen K; Hermsen CC; Koelewijn R; van Hellemond JJ; van Genderen PJJ; Sauerwein RW
    Am J Trop Med Hyg; 2018 Sep; 99(3):709-712. PubMed ID: 30014816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
    Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS
    Malar J; 2009 Oct; 8():235. PubMed ID: 19852802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challenge.
    Talley AK; Healy SA; Finney OC; Murphy SC; Kublin J; Salas CJ; Lundebjerg S; Gilbert P; Van Voorhis WC; Whisler J; Wang R; Ockenhouse CF; Heppner DG; Kappe SH; Duffy PE
    PLoS One; 2014; 9(11):e109654. PubMed ID: 25405724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.
    Triller G; Scally SW; Costa G; Pissarev M; Kreschel C; Bosch A; Marois E; Sack BK; Murugan R; Salman AM; Janse CJ; Khan SM; Kappe SHI; Adegnika AA; Mordmüller B; Levashina EA; Julien JP; Wardemann H
    Immunity; 2017 Dec; 47(6):1197-1209.e10. PubMed ID: 29195810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
    Hickey B; Teneza-Mora N; Lumsden J; Reyes S; Sedegah M; Garver L; Hollingdale MR; Banania JG; Ganeshan H; Dowler M; Reyes A; Tamminga C; Singer A; Simmons A; Belmonte M; Belmonte A; Huang J; Inoue S; Velasco R; Abot S; Vasquez CS; Guzman I; Wong M; Twomey P; Wojnarski M; Moon J; Alcorta Y; Maiolatesi S; Spring M; Davidson S; Chaudhury S; Villasante E; Richie TL; Epstein JE
    PLoS One; 2020; 15(6):e0233840. PubMed ID: 32555601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.
    Tewari K; Flynn BJ; Boscardin SB; Kastenmueller K; Salazar AM; Anderson CA; Soundarapandian V; Ahumada A; Keler T; Hoffman SL; Nussenzweig MC; Steinman RM; Seder RA
    Vaccine; 2010 Oct; 28(45):7256-66. PubMed ID: 20846528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.